Research ArticleCANCER

Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms

See allHide authors and affiliations

Science Advances  07 Feb 2020:
Vol. 6, no. 6, eaav7416
DOI: 10.1126/sciadv.aav7416

Article Information

vol. 6 no. 6

Online ISSN: 
History: 
  • Received for publication October 16, 2018
  • Accepted for publication November 22, 2019
  • .

Author Information

  1. Mark Borris D. Aldonza1,2,3,
  2. Jayoung Ku1,3,
  3. Ji-Young Hong4,
  4. Donghwa Kim4,
  5. Seung Jung Yu1,
  6. Min-Seok Lee1,
  7. Monica Celine Prayogo1,
  8. Stephanie Tan1,
  9. Dayeon Kim5,
  10. Jinju Han5,6,
  11. Sang Kook Lee4,
  12. Sung Gap Im1,
  13. Han Suk Ryu7 and
  14. Yoosik Kim1,3,*
  1. 1Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea.
  2. 2Department of Biological Sciences, KAIST, Daejeon 34141, Korea.
  3. 3KI for Health Science and Technology (KIHST), KAIST, Daejeon 34141, Korea.
  4. 4College of Pharmacy, Seoul National University, Seoul 08826, Korea.
  5. 5Biomedical Science and Engineering Interdisciplinary Program, KAIST, Daejeon 34141, Korea.
  6. 6Graduate School of Medical Science and Engineering (GSMSE), KAIST, Daejeon 34141, Korea.
  7. 7Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea.
  1. *Corresponding author. Email: ysyoosik{at}kaist.ac.kr

Altmetric

Article usage

Article usage: February 2020 to May 2020

AbstractFullPdf
Feb 20201642281709
Mar 202017912163
Apr 20209645118
May 20201047863

Stay Connected to Science Advances

Navigate This Article